Drug Name: | Picibanil (39325-01-4) |
---|---|
PubChem ID: | 640429 |
SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C |
InchiKey: | JGSARLDLIJGVTE-MBNYWOFBSA-M |
Therapeutic Category: |
Molecular Weight (dalton) | : | 333.389 |
LogP | : | -0.4739 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 5 |
Hydrogen Bond Donor Count | : | 1 |
Total Polar Surface Area | : | 89.54 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category
Toxicity | Source |
---|---|
Carcinoma Hepatocellular | MetaADEDB |
Carcinoma Renal Cell | MetaADEDB |
Lung Neoplasms | MetaADEDB |
Neoplasm Metastasis | MetaADEDB |